[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340838-105":59,"doc-detail-340838-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cyp2a6-associates-with-respiratory-disease-risk-and-younger-age-of-diagnosis-a-phenome-wide-association-mendelian-randomization-study","CYP2A6 associates with respiratory disease risk and younger age of diagnosis - a phenome-wide association Mendelian Randomization study","","CYP2A6 is a genetically variable nicotine-inactivating and carcinogen-activating enzyme that also metabolizes many pharmaceuticals; CYP2A6 variation shapes smoking behaviors and tobacco-related disease risk. A phenome-wide association study tested links between a reconstructed CYP2A6 weighted genetic risk score (wGRS) for CYP2A6 activity and diseases in UK Biobank (N=395887), followed by two-sample Mendelian Randomization and survival analyses for disease onset age using nicotine metabolite ratio-derived measures.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cyp2a6-associates-with-respiratory-disease-risk-and-younger-age-of-diagnosis-a-phenome-wide-association-mendelian-randomization-study/340838/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cyp2a6-associates-with-respiratory-disease-risk-and-younger-age-of-diagnosis-a-phenome-wide-association-mendelian-randomization-study/340838.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main aim of this phenome-wide association study?","Question",{"text":113,"@type":114},"To assess associations between a reconstructed CYP2A6 weighted genetic risk score (wGRS) for CYP2A6 activity and diseases across the UK Biobank, and then test causal effects using two-sample Mendelian Randomization.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is CYP2A6 activity characterized in the study?",{"text":118,"@type":114},"CYP2A6 activity is measured using the nicotine metabolite ratio (NMR), defined as 3′-hydroxycotinine/cotinine, which reflects CYP2A6-dependent nicotine metabolism.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings regarding CYP2A6 activity and disease risk?",{"text":122,"@type":114},"Six phenome-wide significant (PWS) signals were identified (two lung cancers and four obstructive respiratory diseases PheCodes), with faster CYP2A6 activity linked to higher disease risk, and faster metabolizer status also associated with younger age of diagnosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340838,1790168453,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Human Molecular Genetics, 2024, Vol. 33, 2, 198–210  \n[https://doi.org/10.1093/hmg/ddad172](https://doi.org/10.1093/hmg/ddad172)  \nAdvance access publication date 6 October 2023  \nAssociation Studies Article  \nCYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study  \nHaidy Giratallah1 , 2 , Meghan J. Chenoweth1 , 2 , 3 , Jennie G. Pouget2 , 3 , Ahmed El-Boraie1 , 2 , Alaa Alsaafin1 , 2 , Caryn Lerman4 , Jo Knight3 , 5 , Rachel F. Tyndale1 , 2 , 3 , *  \n1 Department of Pharmacology and Toxicology, University of Toronto, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada  \n2 Campbell Family Mental Health Research Institute, CAMH, 250 College St, Toronto, ON M5T 1R8, Canada  \n3 Department of Psychiatry, University of Toronto, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada  \n4Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave, Los Angeles, CA 90033, United States  \n5 Data Science Institute, Lancaster University Medical School, Lancaster LA1 4YE, United Kingdom  \n*Corresponding author. Department of Pharmacology and Toxicology, University of Toronto, Rm 4336, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada. E-mail: [r.tyndale@utoronto.ca](r.tyndale@utoronto.ca)  \nAbstract  \nCYP2A6, a genetically variable enzyme, inactivates nicotine, activates carcinogens, and metabolizes many pharmaceuticals. Variation in CYP2A6 influences smoking behaviors and tobacco-related disease risk. This phenome-wide association study examined associations between a reconstructed version of our weighted genetic risk score (wGRS) for CYP2A6 activity with diseases in the UK Biobank (N= 395887) . Causal effects of phenotypic CYP2A6 activity (measured as the nicotine metabolite ratio: 3􀀂 -hydroxycotinine/cotinine) on the phenome-wide significant (PWS) signals were then estimated in two-sample Mendelian Randomization using the wGRS asthe instrument. Time-to-diagnosis age was compared between faster versus slower CYP2A6 metabolizers for the PWS signals in survival analyses. In the total sample, six PWS signals were identified: two lung cancers and four obstructive respiratory diseases PheCodes, where faster CYP2A6 activity was associated with greater disease risk (Ps \u003C 1 × 10−6) . A significant CYP2A6-by-smoking status interaction was found (Psinteraction \u003C0.05); in current smokers, the same six PWS signals were found as identified in the total group, whereas no PWS signals were found in former or never smokers. In the total sample and current smokers, CYP2A6 activity causal estimates on the six PWS signals were significant in Mendelian Randomization (Ps \u003C5 × 10−5) . Additionally, faster CYP2A6 metabolizer status was associated with younger age of disease diagnosis for the six PWS signals (Ps \u003C 5 × 10−4, in current smokers) . These findings support a role for faster CYP2A6 activity as a causal risk factor for lung cancers and obstructive respiratory diseases among current smokers, and a younger onset of these diseases. This research utilized the UK Biobank Resource.  \nKeywords: UK Biobank; nicotine metabolism; CYP2A6 weighted genetic risk score; PheWAS; lung cancer  \nIntroduction  \nCytochrome P450 2A6 (CYP2A6) is a genetically polymorphic enzyme that metabolically inactivates nicotine, activates tobacco-specific nitrosamine carcinogens, and is associated with numerous smoking behaviors [1–3] . CYP2A6 metabolizes many drugs including tegafur, letrozole, and ketamine [4 , 5] . CYP2A6 has numerous star (∗) variant alleles (described in PharmVar) [3] . Single nucleotide polymorphisms (SNPs), in addition to hybrid, duplicated, and deleted CYP2A6 alleles, alter CYP2A6 activity [6 , 7] . Genome-wide association studies (GWASs) have increased our understanding of the SNPs-captured variability in CYP2A6 activity [8 , 9] .  \nA well-established robust biomarker of CYP2A6 activity is the ratio of 3􀀂 -hydroxycotinine/cotinine: the nicotine metabol","cbCaiiddUcWHQvyL","https://ap.wps.com/l/cbCaiiddUcWHQvyL","pdf",1995768,13,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is the main aim of this phenome-wide association study?\",\"answer\":\"To assess associations between a reconstructed CYP2A6 weighted genetic risk score (wGRS) for CYP2A6 activity and diseases across the UK Biobank, and then test causal effects using two-sample Mendelian Randomization.\"},{\"question\":\"How is CYP2A6 activity characterized in the study?\",\"answer\":\"CYP2A6 activity is measured using the nicotine metabolite ratio (NMR), defined as 3′-hydroxycotinine/cotinine, which reflects CYP2A6-dependent nicotine metabolism.\"},{\"question\":\"What were the key findings regarding CYP2A6 activity and disease risk?\",\"answer\":\"Six phenome-wide significant (PWS) signals were identified (two lung cancers and four obstructive respiratory diseases PheCodes), with faster CYP2A6 activity linked to higher disease risk, and faster metabolizer status also associated with younger age of diagnosis.\"}]","CYP2A6 associates with respiratory disease risk and younger age of diagnosis - a phenome-wide association Mendelian Randomization study | PDF",1790039097,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb9b4fd785ddd312b86b5285c753c79b.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e198d9ed00cfd03390ff7d0a96c25f55.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c852e5c06d7a9afc98dfae4a92171c09.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ff10290bd087cbe17b459ec081c09a0.webp",980,1287]